In spite of the clinical importance of allergic disturbances produced by quinines, salicylates, and barbiturates, very few experiments on sensitization to these drugs are published. Landsteiner
(1) wrote in 1936 ". . . there remains the fact that with many simple compounds (quinine, aspirin, antipyrine, iodoform, et cetera) to which certain individuals are highly sensitive artificial sensitization has not yet been effected in man or animals."
The following is a brief review of several of the more recent attempts to induce experimental cutaneous sensitizations of guinea pigs to some of the drugs mentioned in the above quotation from LancLsteiner.
Landsteiner and Jacobs (2) failed to obtain skin sensitization in guinea pigs with quinine and acetyl salicylic acid by their methods (repeated intracutaneous injections, etc.). Morishita did not succeed in producing typical anaphylactic symptoms in guinea pigs or rabbits by quinine. M. Silverberg (4) elicited epidermal hypersensitivity to "mesotan," a salicylic acid compound in man by The following report deals with attempts at experimental specific cutaneous sensitization of guinea pigs to quinine hydrochloride, acetyl salicylic acid, and barbital. Since in former experiments of Landsteiner and Jacobs (2) with two of these drugs (quinine and acetyl salicylic acid) the customary methods of sensitization had failed to give results, in these attempts some special methods were employed. Two of the experiments made use of the sensitization of the guinea pigs' skin to arsphenamine (Frei (6), Sulzberger (7), Landsteiner and Jacobs (8), Frei and Sulzberger (9) et al.) in the attempt to increase the susceptibility to sensitization to the other drugs. The results were uniformly negative. Even in the case of acetyl salicylic acid it was not possible to achieve sensitization. This finding agrees with the results of Landsteiner and Jacobs-and is in contrast to the report of M. Suzuki, who, as above mentioned, stated that he had been able to elicit skin sensitization by means of this drug administered by widely different routes.
In spite of the negative results of the present experiments, it appeared to the author that the significance of the questions which were involved, as well as some additional observations, justify the following short report. EXPERIMENT I It has been learned empirically, for instance, from experience acquired in modern anti-syphilitic therapy, that individuals with allergic hypersensitivity to one drug, when changing to another, are inclined to exhibit allergy to the second or third drug more frequently than does the average, not previously sensitized pa-tient. In some of these cases the allergic disturbances due to the second drug appear shortly after its first administration; in others they appear after a longer lapse of time and perhaps only after several administrations. Thus the impression arises that two groups of "multivalent" drug hypersensitivity might exist, one produced by sensitization to a single drug, and the other by a sequence of sensitizations to different preparations. Similar clinical observations have been made with regard to external allergens in contact-type eczematous dermatitis, and extensive experimental investigations in man have supplied further information here (see Sulzberger (10) In drug hypersensitivity corresponding experimental studies of combined sensitizations are almost entirely lacking. ' The following preliminary experiment deals with the question as to whether previous sensitization to arsphenamine might bring about or augment a later sensitization of the guinea pig's skin to other non-related drugs.
A series of guinea pigs which had acquired a strong allergic hypersensitivity to arsphenamine (old arsphenamine) by intracutaneous injections (6, 7, 8, 9) were treated several months later by frequent intracutaneous injections of either quinine hydrochloride, or acetyl salicylic acid, or barbital. When the particular drug in question was reinjected two and four weeks afterwards, no sign of acquired allergic hypersensitivity could be found, while the cutaneous arsphenamine allergy still persisted (see protocol 1). These negative results correspond to earlier unpublished experiments of Sulzberger with neoarsphenamine plus gold salts,2 and of Frei with arsphenamine plus sulfanilamide.
Protocol 1
On December 13th, 1939, 9 white virgin guinea pigs, each weighing approxiinately 250-300 grams were injected intracutaneously with 0.1 cc. of a solution of 0.1 arsphenamine Hoechst in 100 cc. distilled water. Most of the animals showed spontaneous flare-ups after 6-7 days (6, 7, 8, 9). All of them were proved sensitized to arephenamine when reinjected with a solution of the original strength after four weeks.
Four and one-half months after the first injection of arsphenamine the attempt was made to sensitize the skin of the same 9 animals-now weighing 500-700 grams-to one of the above-mentioned drugs. Each animal received intracutaneous injections of the aqueous solutions twice daily for six consecutive days. In the case of quinine, about 9-10 days after the injections were begun, the papules resulting from the earlier injections became somewhat more elevated and harder without showing any considerable increase of inflammation; some days later the papules resulting from the last injections showed similar changes. When quinine solution of the same strength as that used in the beginning was reinjected intracutaneously two weeks after the start of the first series, the papules of the first series showed a mild focal reaction. The local reaction to these reinjections did not differ in any way from those following the first injections; tiere was also a slight increase in consistency and height of these papules after about 8 days. A second intracutaneous injection after an interval of two more weeks (observed for only 48 hours) gave the same immediate and late reactions as did the first series. No focal reactions were observed at the sites of the previous injections.
A repetition of the series of quinine injections in three other animals sensitized to arsphenamine and in three nonsensitized animals produced the same phenomenon of increase in height and consistency after about 9 days; no difference between the arsphenamine sensitive and the non-sensitive group was observed.
In order to examine whether the focal reactions as described above were of specific character, 10 other guinea pigs previously sensitized to arsphenamine were treated with a series of intracutaneous injections of quinine. Thirteen days after the beginning of this treatment, when the nodule formation was at its height, four of the animals received 0.2 cc. of 0.2 per cent quinine hydrochloride solution, three 0.2 cc. of 1 per cent aminopyrine solution, and three 0.2 cc. of an arsphenamine solution 0.1:4000. However, this time focal reactions at the site of the first quinine injections were not observed in any of the three groups after 24 hours. After 48 hours the results were doubtful in the quinine and in the arsphenamine group and negative in the aminopyrine group. In the case of acetyl salicylic acid, the same phenomenon of increase in consistency of the papules after 9-10 days was observed, but to a lesser degree. Focal reactions following reinjection after two weeks were not seen. R.eineotions after two and four weeks gave no signs of sensitization.
In the case of barbital, no nodule formation-as described above in the case of quinine and acetyl salicylic acid-was seen. No sensitization was obtained after two and four weeks.
When at the end of this experiment, 5 months after the first sensitizing injection of arsphenamine and 41 months after the first reinjection of this preparation, a second intracutaneous reinjection of arsphenamine was made (0.1 cc. of a solution of 0.15:100 arsphenamine Winthrop) the skin of the guinea pigs reacted to arsphenamine as strongly as a series of freshly sensitized control animals reinjected at the same time.
EXPERIMENT 2
Landsteiner (1) et a!., in fundamental experiments on haptens demonstrated that certain simple chemicals acquire sensitizing properties by preliminary conjugation with proteins. Br. Bloch and Steiner-Wourlisch (19), Frei (6), Sulzberger (7), Landsteiner and Jacobs (2) et aL showed later that certain other simple chemicals probably do not require such preliminary conjugation but seem to be capable of producing hypersensitivity by themselves.
This raises the question whether chemicals of the latter kind, such as arsphenamine, may not-in addition to being in themselves full sensitizing agents or full allergens-also complete the action of other chemicals to which they are added.
In the experiments of Landsteiner and van der Scheer (20) , guinea pigs sensitized to certain azoproteins also died in anaphylactic shock when reinjected with preparations which contained the same azo-compound and in which the protein was replaced by resorcinol. In recent experiments of Hedén (21) Forssman antibodies were produced in man by injecting Forssxnan hapten mixed with neoarsphenamine or other chemotherapeutic agents of the benzene group. Hedén interpreted his results as indicating that these chemotherapeutic agents acted like hog serum or other proteins in completing the antigenic property of the hapten.
M. Suzuki (5) reported that in his experiments on sensitization of guinea pigs to acetyl salicylic acid addition of potassium alum or of horse serum intensified noticeably the sensitizing ability of the acetyl salicylic acid. In experiments of Haxthausen (22) in man, simple admixture with horse serum did not suffice to raise the sensitizing power of neoarsphenamine. Only chemicals forming conjugates with horse serum, as mercury bichloride, formaldehyde, or chromic acid, acquired sensitizing properties by admixture.
In analogy of the procedure of Hedén with regard to Forssman hapten, some preliminary experiments were done in which simple mixtures of arsphenamine (old arsphenamine) and of quinine hydrochloride, acetyl salicylic acid, or barbital respectively were injected intracutaneously into a series of guinea pigs on three consecutive days. Four weeks later these animals were tested intracutaneoilsly, first with quinine, acetyl salicylic acid, or barbital alone, and then with mixtures of each drug and of arsphenamine and at the same time with arsphenamine alone.
The skins of the animals did not show any sign of sensitization to quinine, acetyl salicylic acid, or barbital alone. They gave the customary allergic reactions to arsphenamine alone. To mixtures of arsphenamine and the other drugs they reacted in exactly the same manner and with the same intensity as they did to arsphenamine alone (see protocol 2, of Experiment 2). All of the animals gave mild late reactions to the injections. Most of them, after 9-10 days, showed flare-ups of the same papular type as are usually seen after arsphenamine injections. Four weeks after the first injection the animals received an intracutaneous injection of 0.1 cc. of the appropriate drug, i.e., either quinine hydrochloride (0.2 per cent) or acetyl salicylic acid (half saturated) or barbital (half saturated). There was no evidence of sensitization, and the guinea pigs of this experiment gave immediate and late reactions of the same kind and intensity as the animals of experiment I and III reinjected at the same time.
Three days later all of the animals of this series received intracutaneous injections of 0.1 cc. of 1) arsphenamine solution 0.15:100, 2) the same arsphenamine solution containing at the same time 0.2 per cent quinine hydrochloride, 3) the same arsphenamine solution containing acetyl salicylic acid in half saturation, and 4), the same arsphenamine solution containing barbital in half saturation. All of these animals gave allergic reactions to all of the injections. The reactions to the mixtures did not differ in any way from those to pure arsphenamine alone. EXPERIMENT 3 In a third series of guinea pigs, frequently repeated intracutaneous injections of quinine hydrochloride, acetyl salicylic acid, or barbital respectively were made into one and the same area. The same procedure was used by Lehner and Rajka (23) in attempts to sensitize human skin to trichophytin, tuberculin, und luetin. It represents a modification of a method introduced by J. Jadassohu (24) for epidermal sensitization.
In the experiment here reported repeated injections into the same area also did not elicit any positive result (see protocol 3).
Protocol 3
Nine white virgin guinea pigs of the same breed as those used in experiment I and II, and weighing 500-700 grams, received twice daily, on six consecutive days, an intracutaneous injection of 0.1 cc. of one of three aqueous solutions: Three received a solution of 0.2 per cent quinine hydrochloride, three a half saturated solution of acetyl salicylic acid, and three animals received a half saturated solution of barbital. The solutions were freshly prepared every day. The injections were made into the same area, first into the centre and later, after infiltration and ulceration had appeared in the central parts, into the periphery oJ the nodules. There was formation of an ulceration and subsequently of a deep scar at all sites.
Four weeks after the beginning of the injections the animals received, on an intact part of the skin (flank), an intracutaneous reinjection of 0.1 cc. of the same solution with which they were treated previously. There was no sign of sensitization, and the guinea pigs gave iimnediate and late reactions of the same kind and intensity as they had at the beginning of the experiment, and as did the animals of experiment I and II reinjected at the same time.
In the course of the experiments just reported some additional observations were made which may be summarized as follows: a) Guinea pigs first injected with arsphenamine 5 months previously and last tested with the same drug-4 months previously were as sensitive to reinjections of arsphenamine as newly sensitized animals (see Kaplun and Moreinis (25) , Cormia (26) ). b) Full grown guinea pigs of 500-700 grams could be sensitized to arsphenamine (old arsphenamine) with the same ease as younger animals of 250-300 grams (see M. B. Cohen (27) ). This supplements former experiments of the present author (28) who found that the ability of guinea pigs to become sensitized to arsphenamine (neoarsphenamine) begins at the age of three weeks and is fully developed at the age of five weeks. by addition of 0.2 per cent quinine from 2.6 to 3.6. The surface tension of the solution was not changed by the addition. Despite these apparent changes, the sensitizing capacity of the arsphenamine and its ability to elicit skin reactions in previously sensitized guinea pigs were apparently unaltered.
d) The same guinea pigs showed no differences in the intensity of allergic skin reactions to arsphenamine whether one injected full or half strength solutions, whether the injected amount was 0.1 cc. or a little more or less, whether the injection was made very superficially or a little more deeply. However, among the individual animals there were strong differences in the reactivity even to one and the same solution applied exactly in the same way and in the same quantity. e) In guinea pigs treated with quinine hydrochloride, hard, slightly inflammatory nodules of about the size of a rice grain developed at the sites of the deposits some days after a series of intracutaneous injections. Similar nodules were also observed after injections of other chemicals e.g. of acetyl salicylic acid (see also Landsteiner and Jacobs (2)). In the case of quinine, the nodules were especially large so that the suspicion of a small "flare-up" arose, which, if true, would have meant the beginning of a sensitization. The suspicion was strengthened by a mild focal reaction appearing at the sites of the nodules of first injection after an intracutaneous reinjection of quinine at a remote site. However, the animals proved to be non-sensitized. This was indicated by several findings, among them the observation that the local reactions to intracutaneous reinjections to quinine in new skin areas did not differ in any way from those to the first injections. This phenomenon of focal reaction turned out to be inconstant. In order to see whether it was of specific character, another series of guinea pigs was prepared by quinine in the same way. No definite focal reactions to quinine or other substances were observed this time at the sites of the nodules after reinjections (see protocol 1).
The nodules apparently represent the product of a non-specific inflammation and correspond to inflammatory nodules which may develop in man after subcutaneous injections of certain drugs, e.g., phenobarbital sodium or codeine and without sensitization to these drugs. Also in man mild focal reactions are sometimes observed after reinjections of those agents or even after oral intake without there being any sign of allergic sensitivity to the particular drug.3
SUMMARY
In the attempt to achieve cutaneous sensitization of guinea pigs to quinine hydrochloride, to acetyl salicylic acid, or to barbital, three different methods were used: 1) repeated intracutaneous injections into animals whose skins had first been specifically sensitized to old arsphenamine. 2) repeated intracutaneous injections of in vitro mixtures of each of these drugs and of old arsphenamine. 3) repeated intracutaneous injections into the same area.
None of these methods gave positive results, and no synergistic or potentiating action was found.
Some additional observations made in the course of these experiments are reported.
